Reditux 100 Mg Injection

Product Description

Product introduction

Reditux 100 Injection is used in the treatment of non-Hodgkin lymphoma (NHL), rheumatoid arthritis, blood cancer (chronic lymphocytic leukemia), granulomatosis with polyangiitis and microscopic polyangiitis.

Reditux 100 Injection is given as an injection under the supervision of doctor. You must take it in a dose as advised by the doctor. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.

The most common side effects of this medicine include headache, weakness, edema, infection, and hair loss. This medicine may reduce the number of blood cells (decrease red blood and white blood cells) in your blood, thereby, increasing the susceptibility to infections. Regular blood tests are required to check your blood cells along with hepatitis B.

Before taking it, tell your doctor if you have heart disease, liver, or planning surgery or vaccination or are taking any medicines to treat infections. Many other medicines can affect, or be affected by, this medicine so let your doctor know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy.

What is Reditux 100 mg Injection?

Reditux 100 mg Injection contains Rituximab, a monoclonal antibody designed to target and reduce abnormal immune activity or cancerous cell growth. Recommended for use in Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Rheumatoid Arthritis, Granulomatosis with Polyangiitis, and Microscopic Polyangiitis, it functions as both an anti-cancer and disease-modifying drug. Administration is via intravenous infusion by medical professionals.


How is Reditux 100 mg Injection Administered?

This medicine is administered in a hospital or clinic by qualified healthcare staff through intravenous infusion. Dosage and frequency are determined by the treating physician, commonly starting at 375 mg/m2 weekly for four weeks or as prescribed. Self-administration is strictly prohibited due to the potential risks of infusion reactions and other adverse effects.


What Benefits Does Reditux Offer?

Reditux provides significant benefits in treating certain cancers and autoimmune conditions by selectively targeting B-cells, which are implicated in disease progression. This can result in reduced symptoms, slowed disease advancement, and improved patient outcomes. The medication is DCGI-approved and presents an accessible alternative to the international brand Rituxan.